Esophageal Adenocarcinoma

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment locally at low-volume centers, according to results of a cohort study.

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.

Several notable guideline updates have been made in gastroenterology and hepatology for the diagnosis, management and treatment of GI and liver disorders. Wondering what you may have missed?

ORLANDO — Adults with obesity who reduce their body weight lower their odds for developing an obesity-related cancer, according to data presented at the American Diabetes Association Scientific Sessions.

CHIGAGO — Perioperative chemotherapy improved OS in patients with locally advanced esophageal adenocarcinoma compared with chemoradiation prior to surgery, results form a randomized phase 3 trial presented at ASCO Annual Meeting showed.

More than 300 million people worldwide, including one in every 10 Americans, are living with a rare disease, yet these individuals and their families are often left isolated and without answers.

Two different treatment regimens showed efficacy among patients with gastroesophageal cancers, according to study results presented during an ASCO Plenary Series session.

Patients with Barrett’s esophagus who underwent anti-reflux surgery had an increased risk for esophageal adenocarcinoma over time compared with patients who used anti-reflux medication, according to research.

A new machine-learning tool accurately predicted incident esophageal and gastric cardia adenocarcinoma using electronic health record data, according to a report published in Gastroenterology.

Men appeared to have a higher risk for cancer than women at most shared anatomic sites, according to study results published in Cancer.